Stealth BioTherapeutics Inc. - Company Profile
Powered by 
All the data and insights you need on Stealth BioTherapeutics Inc. in one report.
$295
- Save hours of research time and resources with
our up-to-date Stealth BioTherapeutics Inc. Strategy Report
- Understand Stealth BioTherapeutics Inc. position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Stealth BioTherapeutics Inc (Stealth BioTherapeutics), formerly Stealth Peptides International Inc is a clinical stage biopharmaceutical company which focuses on the discovery, advancement, and marketing of novel therapies for diseases associated with mitochondrial dysfunction The company's lead candidate, elamipretide, is a small peptide which binds reversibly to cardiolipin to stabilize mitochondrial structure and function under conditions of oxidative stress.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Stealth BioTherapeutics research and development activities focuses on development of its preclinical and clinical product candidates for the treatment of diseases associated with mitochondrial dysfunction.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer